Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | TP53 | P04637 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL139563 | 0.98 | ALDH1A1 (0.62) | DNM1ALDH1A1KDM4ETDP1MEN1 | |
| Water SCHEMBL27613448 | 0.98 | HTT (0.58) | DNM1ALDH1A1KDM4ETDP1MEN1 | |
| Iodide SCHEMBL5088129 | 0.98 | DNM1 (0.57) | DNM1ALDH1A1KDM4ETDP1MEN1 | |
| Water SCHEMBL2959266 | 0.98 | DNM1 (0.57) | DNM1ALDH1A1KDM4ETDP1MEN1 | |
| Hydrochloric Acid SCHEMBL14762882 | 0.98 | ALDH1A1 (0.62) | DNM1ALDH1A1KDM4ETDP1MEN1 | |
| Bromide SCHEMBL4071102 | 0.98 | DNM1 (0.60) | DNM1ALDH1A1KDM4ETDP1MEN1 | |
| Water SCHEMBL10667376 | 0.95 | HTT (0.61) | DNM1ALDH1A1KDM4ETDP1MEN1 | |
| Hydrochloric Acid SCHEMBL27795002 | 0.95 | ALDH1A1 (0.60) | DNM1ALDH1A1KDM4ETDP1MEN1 | |
| Ammonia Solution, Strong SCHEMBL27810167 | 0.95 | ALDH1A1 (0.60) | DNM1ALDH1A1KDM4ETDP1MEN1 | |
| Hydrochloric Acid SCHEMBL8067974 | 0.93 | KDM4E (0.58) | DNM1ALDH1A1KDM4ETDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12620595-B2 | Increased capacity battery cell using reservoir replenishing additives | SOUTH 8 TECHNOLOGIES, INC. (US) | 2026-05-05 | — | — | US | claimed |
| US-20260051512-A1 | Increased Capacity Battery Cell Using Reservoir Replenishing Additives | SOUTH 8 TECH INC (US) | 2026-02-19 | — | — | US | claimed |
| WO-2025230533-A1 | APPARATUS AND METHOD OF LIQUEFIED GAS ELECTROLYTE PREPARATION | SOUTH 8 TECHNOLOGIES, INC. (US) | 2025-11-06 | — | — | WO | claimed |
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | nanoSUR LLC | 2025-04-10 | — | — | US | claimed |
| US-12252632-B2 | Chemical-mechanical polishing composition, rinse composition, chemical- mechanical polishing method, and rinsing method | ENTEGRIS, INC. (US) | 2025-03-18 | — | — | US | claimed |
| US-20240174523-A1 | SYNTHESIS OF ZEOLITIC MATERIAL HAVING AFT FRAMEWORK STRUCTURE AND SCR CATALYSTS COMPRISING THE SAME | BASF CORPORATION | 2024-05-30 | — | — | US | claimed |
| US-20240120543-A1 | CHEMICALLY INERT ADDITIVES FOR ELECTROCHEMICAL CELLS | SOUTH 8 TECH INC (US) | 2024-04-11 | — | — | US | claimed |
| EP-4348752-A1 | CHEMICALLY INERT ADDITIVES FOR ELECTROCHEMICAL CELLS | South 8 Technologies, Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| US-11903380-B2 | Aqueous composition based on polyoxymethylene dialkyl ethers (POM) and their use for the preservation and/or embalming of the human or animal body | ARKEMA FRANCE (FR) | 2024-02-20 | — | — | US | claimed |
| EP-4313864-A1 | SYNTHESIS OF ZEOLITIC MATERIALS HAVING AFT FRAMEWORK STRUCTURE AND SCR CATALYSTS COMPRISING THE SAME | BASF Corporation (US) | 2024-02-07 | — | — | EP | claimed |
| US-6242526-B1 | MONOMER UNIT IS DERIVED FROM AN ETHYLENICALLY UNSATURATED MONOMER AND THE SURFACE ACTIVE AGENT UNIT IS DERIVED FROM A POLYMERIZABLE ANTIBACTERIAL QUATERNARY AMMONIUM COMPOUND. | STEPAN COMPANY | 2001-06-05 | — | — | US | claimed |
| WO-2000006612-A1 | ANTIMICROBIAL POLYMER LATEXES DERIVED FROM UNSATURATED QUATERNARY AMMONIUM COMPOUNDS AND ANTIMICROBIAL COATINGS, SEALANTS, ADHESIVES AND ELASTOMERS PRODUCED FROM SUCH LATEXES | STEPAN COMPANY (US) | 2000-02-10 | — | — | WO | claimed |
| EP-0599367-B1 | Focused ion beam processing with charge control | SCHLUMBERGER TECHNOLOGIES INC (US) | 1996-05-15 | — | — | EP | claimed |
| US-5357116-A | Focused ion beam processing with charge control | SCHLUMBERGER TECHNOLOGIES, INC. (US) | 1994-10-18 | — | — | US | claimed |
| EP-0599367-A1 | Focused ion beam processing with charge control | SCHLUMBERGER TECHNOLOGIES, INC. (US) | 1994-06-01 | — | — | EP | claimed |
| EP-0294651-B1 | PROCESS FOR THE PREPARATION OF (2,2)-PARACYCLOPHANE | UNION CARBIDE CORPORATION (US) | 1991-02-27 | — | — | EP | claimed |
| EP-0299164-B1 | PROCESS FOR THE PREPARATION OF 2,2-PARACYCLOPHANE | UNION CARBIDE CORPORATION (US) | 1990-09-19 | — | — | EP | claimed |
| EP-0021799-B1 | PROCESS FOR EXTRACTION CLEANING OF CARPETING | S.C. JOHNSON & SON, INC. (US) | 1985-06-05 | — | — | EP | claimed |
| EP-0034126-B1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS FOR SHAVING THE SKIN | Maggesi, Luigi (IT) | 1984-07-04 | — | — | EP | claimed |
| US-3983175-A | FROM ORGANIC HALIDE AND A KETONE | KURARAY CO., LTD. (JA) | 1976-09-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | NSUN2, NSUN3, RNGTT | DNM1 1601/4885ALDH1A1 3764/4885KDM4E 1117/4885 |
| US-12620595-B2 | Increased capacity battery cell using reservoir replenishing additives | SLC9A2, SLC8A1, CA2 | DNM1 4433/4885ALDH1A1 2912/4885KDM4E 1664/4885 |
| US-20260051512-A1 | Increased Capacity Battery Cell Using Reservoir Replenishing Additives | SCO2, CA2, SLC9A2 | DNM1 3675/4885ALDH1A1 849/4885KDM4E 2084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.